← Back to All Filings

SCHEDULE 13D/A Filing: ArriVent BioPharma, Inc.

Not Yet AnalyzedOctober 8, 2026 at 10:42:07 PM UTC

ArriVent BioPharma, Inc.

$AVBPSCHEDULE 13D/ACIK: 0001868279

Subscribe to track AVBP

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

SCHEDULE 13D/A Filing

Company: ArriVent BioPharma, Inc. Filed: 2026/10/08

View Filing

Topics:#SECFiling#SCHEDULE13DA#StockAlert

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.